Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV-MPL Vaccine vs Engerix-B in Healthy Adults
NCT00697229Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 1992
- Primary completion
- May 1996
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of hepatitis b vaccine recombinant AS04-adjuvanted in hepatitis B (HBV) (8 arms), sponsored by GSK. Primary endpoint: Anti-hepatitis B surface antigen antibody concentrations at 71 months. Started Sep 1992; status: completed.
02
Drugs
hepatitis b vaccine recombinant AS04-adjuvanted
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00697229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697229.